Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: Enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms

Human Reproduction

Volumn 11, Issue 7, 1996, Pages 1533-1537

  Neulen, Joseph ^a,b   Williams, Robert F ^a   Breckwoldt, Meinert ^b   Chwalisz, Krzysztof ^c   Baulieu, Etienne E ^d   Hodgen, Gary D ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BAYER PHARMA AG   (Germany)

^d BICÊTRE HOSPITAL   (France)

Author keywords

Anti oestrogenic; Endometrium; Progesterone antagonist; Proliferation; Receptors

Indexed keywords

ANTIESTROGEN; ANTIGESTAGEN; ESTRADIOL; ESTROGEN RECEPTOR; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; NONHUMAN; OVARIECTOMY; PRIMATE; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; MACACA; MACACA FASCICULARIS; PRIMATES;

EID: 0029809449     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019433     Document Type: Article

References (35)

1. Baulieu, E.E. (1991) On the mechanism of action of RU 486. In Seppälä, M. and Hamberger, L. (eds), Frontiers in Human Reproduction. Ann. N.Y. Acad. Sci., 626, 545-560.
2. Baulieu, E.E. and Segal, S.J. (eds) (1985) The Antiprogestin Steroid RU 486 and Human Fertility Control. Plenum Press, New York.
3. Beck, C.A. and Garner, C.W. (1989) Characterization and estrogen regulation of growth factor activity from uterus. Mol. Cell. Endocr., 63, 93-101.
4. Berthois, Y., Salat-Baroux, J., Cornet, D. et al. (1991) A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil. Steril., 55, 547-554.
5. Boehm, K.D., Daimon, M., Gorodeski, I.G. et al. (1990) Expression of insulin-like and platelet derived growth factor genes in human uterine tissues. Mol. Reprod. Dev., 27, 93-101.
6. Chwalisz, K., Hegele-Hartung, C., Fritzemeier, K.H. et al. (1991) Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors. Endocrinology, 129, 312-322.
7. Chwalisz K., Hsiu, J.G., Williams, R.F. and Hodgen, G.D. (1992) Evaluation of the antiproliferative actions of the progesterone antagonists mifepristone (RU 486) and onapristone (ZK 98 299) on primate endometrium. Presented at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas.
8. Cordon-Cardo, C., Vlodavsky, I., Haimovitz-Friedman, A. et al. (1990) Expression of basic fibroblast growth factor in normal human tissue. Lab. Invest., 63, 832-840.
9. Gravanis, A., Schaison, G. and George, M. (1985) Endometrial and pituitary responses to steroidal antiprogestin RU 486 in postmenopausal women. J. Clin. Endocrinol. Metab., 60, 156-163.
10. Haluska, G.J., West, N.B., Novy, M.J. and Brenner, R.M. (1990) Uterine estrogen receptors are increased by RU 486 in late pregnant rhesus macaques but not after spontaneous labor. J. Clin. Endocrinol. Metab., 70, 181-186.
11. Haras, D., Samperez, S. and Jouan, P. (1989) Positive and negative effects of estradiol-17β in the rat uterus. J. Steroid Biochem., 33, 1073-1080.
12. Hill, N.C.W., Rivera, J., Lopez, A. and McKenzie, I.Z. (1990) The effect of RU 38,486 on progesterone and oestrogen receptor concentrations in the decidua and placenta in early pregnancy. Hum. Reprod., 5, 464-467.
13. Hissom, J.R., Bowden, R.T. and Moor, M.R. (1989) Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenase in human breast cancer cell line T47D. Endocrinology, 125, 418-423.
14. Hodgen, G.D. (1991) Antiprogestins: the political chemistry of RU 486. Fertil. Steril., 56, 394-396.
15. Ishihara, S., Taketani, Y. and Mizuno, M. (1990) Epidermal growth factor-like immunoreactivity in human endometrium. Asia-Oceania J. Obstet. Gynaecol., 16, 165-168.
16. Kassis, J.A., Sakai, D., Walent, J.H. and Gorski, J. (1984) Primary cultures of estrogen-responsive cells from rat uteri: induction of progesterone receptors and a secretion protein. Endocrinology, 114, 1558-1566.
17. Klein-Hitpass, L., Cato, A.C.B., Henderson, D. and Ryffel, G.U. (1991) Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucl. Acids Res., 19, 1227-1234.
18. Koering, M.J., Healy, D.L. and Hodgen, G.D. (1986) Morphologic response of endometrium to a progesterone receptor antagonist, RU 486, in monkeys. Fertil. Steril., 45, 280-287.
19. Kreitmann-Gimbal, B., Goodman, A.L., Bayard, F. and Hodgen, G.D. (1979) Characterization of estrogen and progesterone receptors in monkey endometrium: methodology and effects of estradiol and progesterone on endometrium of castrate monkeys. Steroids, 34, 749-770.
20. Lessey, B.A., Metzger, D.A., Haney, A.F. and McCarty, K.S. (1989) Immunohistological analysis of estrogen and progesterone receptor in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil. Steril., 51, 409-415.
21. Liu, J.H., Garzo, V.G. and Yen, S.S.C. (1988) Pharmacodynamics of the antiprogesterone RU 486 in women after oral administration. Fertil. Steril., 50, 245-251.
22. McDonnell, D.P. and Goldman, M.E. (1994) RU 486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J. Biol. Chem., 269, 11945-11949.
23. Murphy, A.A., Kettel, L.M., Morales, A. and Yen, S.S.C. (1991) Response of uterine fibroids to the antiprogesterone RU 486: a pilot study. 47th Annual Meeting of the American Fertility Society Meeting, Orlando, Florida.
24. Neef, G., Beier, S., Elger, W., Henderson, D. and Wiechert, R. (1984a) New steroids with antiprogestational and antiglucocorticoid activities. Steroids, 44, 349-372.
25. Neef, G., Sauer, G., Seeger, A.T., Wiechert, R. (1984b) Synthetic variations of the progesterone antagonist RU 38486. Tetrahedron Letters, 25, 3425-3428.
26. 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro. Arch. Gynecol., 240, 225-232.
27. Neulen, J., Williams, R.F. and Hodgen, G.D. (1990) RU 486 (mifepristone): induction of dose-dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J. Clin. Endocrinol. Metab., 71, 1074-1075.
28. Philibert, D., Moguilewsky, M., Mary, I. (1985) Pharmacological profile of RU 486 in animals. In Baulieu, E.E. and Segal, S.J. (eds), The Antiprogestin Steroid RU 486 and Human Fertility Control. Plenum Press, New York, pp. 49-68.
29. Reese, C.C., Warshaw, M.L., Murai, J.T. and Siiteri, P.K. (1988) Alternative models for estrogen and androgen regulation of human breast cancer cell (T47D) growth. In Frairia, R., Bradlow, H.L. and Gaidano, G. (eds), Steroid-Protein Interactions: Basic and Clinical Aspects. Ann. N.Y. Acad. Sci., 158, 113-121.
30. Renoir, J.M., Radanyi, C. and Baulieu, E.E. (1989) The antiprogesterone RU 486 stabilizes the heterooligomeric, non DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor. Steroids, 53, 1-20.
31. Reynolds, R.K., Talavera, F., Roberts, J.A. et al. (1990) Regulation of epidermal growth factor and insulin-like growth factor receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures. Gynecol. Oncol., 38, 396-406.
32. Teutsch, G. (1984) 11-β-substituted 19-norsteroids: at the crossroads between hormone agonists and antagonists. In Agarwal, M.K. (ed.), Adrenal Steroid Antagonism, Walter de Gruyter, Berlin, p. 43.
33. van Look, P.F.A. and Bygdeman, M. (1989) Antiprogestational steroids: a new dimension in human fertility regulation. In Milgan, S. (ed.), Oxford Reviews of Reproductive Biology, Oxford University Press, p. 2.
34. Wiechert, R., Neef G. (1987) Synthesis of antiprogestational steroids. J. Steroid Biochem., 27, 851-858.
35. Wolf, J.P., Hsiu, J.G., Anderson, T.L. et al. (1989) Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril., 52, 1055-1060.